Detalhe da pesquisa
1.
Efficacy and Safety of Remogliflozin Etabonate, a New Sodium Glucose Co-Transporter-2 Inhibitor, in Patients with Type 2 Diabetes Mellitus: A 24-Week, Randomized, Double-Blind, Active-Controlled Trial.
Drugs
; 80(6): 587-600, 2020 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-32162274
2.
Hansen's Neuritis Revisited - A Clinicopathological Study.
J Neurosci Rural Pract
; 9(1): 42-55, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-29456344